Cleared Traditional

K855227 - MICRO-EIA THEOPHYLLINE TEST KIT MONOCLONAL

K855227 is an FDA 510(k) clearance for MICRO-EIA THEOPHYLLINE TEST KIT MONOCLONAL, manufactured by Bioclinical Systems, Inc.. The device is a Class 2 Toxicology device with product code KLS cleared through the Traditional 510(k) pathway after a 102-day FDA review.

K855227 · Bioclinical Systems, Inc. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1986
Decision
102d
Days
Class 2
Risk

K855227 is an FDA 510(k) clearance for the MICRO-EIA THEOPHYLLINE TEST KIT MONOCLONAL. Classified as Enzyme Immunoassay, Theophylline (product code KLS), Class II - Special Controls.

Submitted by Bioclinical Systems, Inc. (St.Louis, US). The FDA issued a Cleared decision on April 11, 1986 after a review of 102 days - within the typical 510(k) review window.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3880 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Toxicology review framework, consistent with the majority of Class II 510(k) submissions.

View all Bioclinical Systems, Inc. devices

FDA 510(k) Submission Details - K855227

510(k) Number K855227 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 30, 1985
Decision Date April 11, 1986
Days to Decision 102 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
15d slower than avg
Panel avg: 87d · This submission: 102d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KLS Device Classification - Class 2, Special Controls

Product Code KLS Enzyme Immunoassay, Theophylline
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3880
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - KLS Enzyme Immunoassay, Theophylline

All 62
Devices cleared under the same product code (KLS) and FDA review panel - the closest regulatory comparables to K855227.
VISION THEOPHYLLINE - ADDIT. OF WHOLE BLOOD CLAIM
K860464 · Abbott Laboratories · Jun 1986
EMIT CAFFEINE ASSAY
K853872 · Syva Co. · Jun 1986
KODAK EKTACHEM CLINICAL CHEMISTRY SLIDES (THEO)
K861367 · Eastman Kodak Company · May 1986
IN VITRO TEST DETERMINATION OF THEOPHYLLINE
K854183 · Clinical Data, Inc. · Dec 1985
VISION THEOPHYLLINE
K853834 · Abbott Laboratories · Oct 1985
GEMSTAR IPA THEOPHYLLINE TEST KIT
K853372 · Electro-Nucleonics Laboratories, Inc. · Sep 1985